Headshot

Dr. Subramaniam (Subbu) Ramanarayanan

Managing Director

Contact

New York City
Tel: +1 212 345 0745
Fax: +1 212 345 4650

Los Angeles
Tel: +1 213 346 3038
Fax: +1 213 346 3030

Email: subbu.ramanarayanan@nera.com
vCard: Download

Education

PhD in managerial economics and strategy, Kellogg School of Management, Northwestern University
MBA, Indian Institute of Management (Calcutta)
B.Tech. in electrical engineering, India Institute of Technology

Experience

Dr. Subbu Ramanarayanan directs NERA’s Health care Antitrust practice and is an adjunct Associate professor of Competitive Strategy at UCLA Anderson School of management. Dr. Ramanarayanan has extensive experience advising clients on antitrust reviews of proposed mergers and acquisitions before the Federal (FTC and DOJ) and State antitrust agencies across a variety of settings in health care including hospital services, health insurance, physician services, medical devices, group purchasing organizations, dialysis services, pharmaceuticals distribution and benefits management services. Most recently, he was the lead economist retained by counsel for the merging Parties in the formation of Beth Israel Lahey Health, a complex multi-billion dollar transaction involving five merging hospital systems that was ultimately cleared by the Federal Trade Commission after an 18-month investigation. 

Dr. Ramanarayanan also has an active practice focused on litigation around liability and damages issues in health care antitrust, and has analyzed issues pertaining to market definition and market power, alleged monopolization, monopsony, exclusive contracting, price-fixing, tying, bundling and alleged foreclosure.

Dr. Ramanarayanan is recognized as a Future Leader in Who’s Who Legal: Competition, and was nominated as one of five finalists for “Competition Economist of the Year” by Global Competition Review in 2019. He is an Associate Editor of the Antitrust Law Journal and has written extensively on the nature of competition in health care markets and its impact on health care costs and quality. He has published articles in the Antitrust Law Journal, and Antitrust Magazine, as well as leading peer-reviewed economics journals, such as the American Economic Review and the Journal of Law and Economics. Notably, he is a two-time winner of the Antitrust Writing Award from the Institute of Competition Law, for his articles examining potential competition mergers (2017) and innovation effects of mergers (2019). Dr. Ramanarayanan has also acted as an academic reviewer to many leading journals in the fields of economics and management.

Title Type Author
Taking Stock of the Efficiencies Defense: Lessons from Recent Health Care Merger Revi... Published Article Dr. Subramaniam Ramanarayanan
The Increasing Cross-Border Importance of Innovation in Merger Review Published Article By Jennifer Cascone Fauver, Dr. Subramaniam (Subbu) Ramanarayanan, and Dr. Nicola Tosini
Expert Witnesses in Competition Disputes Published Article By Dr. David Blackburn, Nathan Blalock, Dr. Subbu Ramanarayanan, and Dr. Paul Wong
Reduced-Form Versus Structural Econometric Methods in Market Definition: Lessons from... Published Article Dr. Subbu Ramanarayanan and Dr. Paul Wong
Paper Trail: Review of a Recent Working Paper on the Effect of Copay Coupons on Drug ... Published Article Bryan Ray and Dr. Subbu Ramanarayanan
Challenges for Economic Analysis of Mergers Between Potential Competitors: Steris and... Published Article By Jennifer Cascone Fauver and Subramaniam (Subbu) Ramanarayanan
Diversion Analysis as Applied to Hospital Mergers: A Primer Published Article By Dr. Subramaniam (Subbu) Ramanarayanan
A Profile of Professor Martin S. Gaynor (Director, FTC Bureau of Economics) Published Article By Dr. Subramaniam (Subbu) Ramanarayanan